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1. Introduction 
Carnitine serves as a carrier of acyl groups into and 
out of mitochondria nd hence is considered to have 
a central function in the metabolic utilization and 
synthesis of fatty acids [l-4]. In the rat, the species 
most extensively studied, adipose tissue, heart, 
kidney and skeletal muscle catalyze the entire sequence 
of reactions from e-N-trimethyl-L-lysie to r-butyro- 
betaine; the same tissues, however, are reported not 
to hydroxylate the latter compound to carnitine 
[5-81. Indeed, several studies uggested that the liver 
is the primary site of carnitine biosynthesis, and that 
the testis is a secondary site with much less capacity 
for such synthesis [6-91. In fact it has been considered 
that extrahepatically s nthesized y-butyrobetaine is
converted to carnitine xclusively in the liver, and 
that the carnitine so formed is rapidly transported to 
other organs [7,10]. 
That species differences may exist in tissue localiza- 
tion of carnitine synthesis was evidenced by the find- 
ing that, in the sheep, kidney and muscle tissues have 
significant capacity to hydroxylate y-butyrobetaine, 
albeit relatively low as compared with liver (11). 
More recently, crude extracts from kidneys of cat, 
hamster, rabbit, and a single Rhesus monkey were 
shown to convert y-butyrobetaine tocamitine [12,131. 
In those species, the levels of y-butyrobetaine- 
hydroxylating activity in kidney nearly equaled or 
exceeded that measured in the corresponding liver. 
In contrast, dog, guinea pig, mouse and rat kidney 
exhibited little or no capacity to hydroxylate y-butyro- 
betaine. 
In this study, in which additional primate species 
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were examined, evidence is provided that the specific 
activity of r-butyrobetaine hydroxylation in crude 
extracts of kidneys of Rhesus monkeys was signifi- 
cantly higher than that of extracts of Rhesus monkey 
livers. In contrast, the extracts of kidneys of Cebus 
monkeys, in comparison to Cebus monkey livers, 
exhibited considerably less capacity for y-butyro- 
betaine hydroxylation. In the human, the specific 
activity of hydroxylase in kidney extracts was con- 
siderably higher than that of corresponding liver 
extracts; and skeletal muscle showed no detectable 
activity. 
2. Experimental procedures 
2.1 . Ma tetils 
y-[2,3-3H]Butyrobetaine was synthesized as in 
[13] and had spec. act. 2.58 X lo6 dpm/pmol. 
2.2. Tissue sources 
Nine monkeys (7 Macaca mulata, 2 Cebus apella) 
ranging in age from 3-5 years, were used. Kidneys 
and livers were removed from anesthetized animals 
(Nembutal, 50-70 mg/kg, i.p.) and immediately 
frozen in liquid nitrogen. Human tissue samples were 
obtained from randomly selected autopsies performed 
at the Albert Einstein College of Medicine Hospital 
between July and December 1978. The intervals 
between death and autopsy ranged from 2.5-12 h, 
and tissues were obtained within 15 min after the 
autopsy was started and immediately frozen in liquid 
nitrogen. In each case, samples were removed from 
organs at sites that grossly appeared to be most 
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nearly ‘normal’ or least unaffected; special care was 
taken, in this regard, in the sampling of livers from 
the two persons with metastatic carcinoma. The 
striated muscle sample was obtained from the inter- 
costal region. In the notes accompanying table 1 are 
summarized the relevant gross and microscopic 
features of the tissues as given in the final autopsy 
report. 
2.3. Preparation of tissue extracts 
Weighed portions of each tissue were homogenized 
in exactly 2 vol. 20 mM Tris-HCl (PH 7.4) containing 
2 mM monothioglycerol (and occasionally, as noted 
in table 1, also containing 1% Triton X-100) with a 
PT 1035 Polytron homogenizer adapted with a PT 
1OST sawtooth generator. The homogenates were 
centrifuged for 1 h at 105 000 X g; the resulting 
supernatants were decanted through glass wool to 
remove floating fat particles and stored on ice until 
assayed. Protein in the high speed supernates was 
determined by the Lowry method [ 141 with crystalline 
bovine serum albumin as a standard. 
2.4. Enzyme assays 
yButyrobetaine hydroxylase activity was assayed 
asin [12,13].The reactionmixtures(0.51 ml)con- 
tailed: Tris-HCI (pH 7.7) 50 mM; Fe(NH4)s(S0&, 
2 mM; sodium ascorbate, 15 mM; a-ketoglutarate, 
2.50 mM; KCl, 20 mM; catalase, 1.5 mg ; 150-200 /.d 
tissue extract;y-[2,3-3H]butyrobetaine, 1.18 mM 
(1.5 1 X 1 O6 dpm/assay tube). Incubations were 
carried out at 37°C for 60 min, reactions being 
initiated by addition of substrate and terminated by 
addition of 50 pm01 2,2’-bipyridine-HCl. Water of 
the medium was collected by sublimation as in [ 131 
for measurement of radioactivity. With the noted 
specific activity of the substrate used in this study 
and the known stereospecitic displacement of only 
1 out of the 4 labeled hydrogen atoms of the sub- 
strate on hydroxylation [151, and with a correction 
made for an observed isotope effect that under- 
estimates the extent of hydroxylation by a factor of 
nearly lo-fold [ 131, the release into the medium of 
645 dpm ‘HsO/O.5 1 ml assay mixture is equivalent to 
formation of -10 nmol carnitine. For purposes of 
comparison with other recently published ata [ 161, 
y-butyrobetaine hydroxylase activity in tissue xtracts 
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is expressed as specific activity in terms of nkat (nmol. 
S-r)/g protein in the 105 000 X g supernatants. 
3. Results and discussion 
The results as presented in table 1 allow direct 
comparison of the specific activities of y-butyro- 
betaine hydroxylase for all tissue extracts analyzed. 
For any particular tissue derived from the same 
individual, comparable specific activities were obtained 
for y-butyrobetaine hydroxylase in extracts prepared 
with buffer containing only monothioglycerol, 
whether assayed in the absence or presence of 0.3% 
Triton X-100. Also, for different samples of the same 
organ extracted with or without 1% Triton X-100 in 
the extracting buffer or for different samples of the 
same tissue extracted after storage in the frozen state 
for varying number of days, comparable specific 
activities were determined. 
A consistently relatively high activity was observed 
in all of the human kidney extracts, with an av. spec. 
act. 14.6 + 4.5 nkat/g protein. In contrast, the 
average specific activity of the human liver extracts 
examined was 1.02 + 0.48 nkat/g protein; the values 
for the 2 patients with liver metastatic carcinoma 
were in the lower range. Average specific activities 
recalculated from reported data for 3 autopsy liver 
samples [ 171 and for 3 surgical liver biopsy samples 
[16],gavevaluesof2.7*0.5and9.6+3.4nkat/g 
protein, respectively. A major cause of the dis- 
crepancy in the results probably relates to differences 
in assay conditions. No detectable y-butyrobetaine 
hydroxylase activity was found in human muscle, 
confirming a recent report [ 161. 
For each of the 7 Rhesus monkeys examined in 
this study, the specific activity of y-butyrobetaine 
hydroxylase in extracts of kidney tissue was signifi- 
cantly higher than that determined inthe extracts of the 
corresponding livers; an average of 18.8 f 6.2 nkat/g 
protein for the kidneys compared to 11.2 + 5.3 nkat/g 
protein for the liver extracts. In contrast, the 
Cebus monkey kidney had very little capacity for 
y-butyrobetaine hydroxylation compared to an av. 
spec. act. 3.92 f 1.14 nkat/g protein for the Cebus 
liver extracts. The last value agrees with y-butyro- 
betaine hydroxylase activities of 4.2 and 4.4 nkat/g 
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protein for ovine [ 1 l] and rat [ 121 liver, respectively. 
The finding of y-butyrobetaine hydroxylase 
activity in kidneys of Rhesus monkeys and humans 
that equals or exceeds that present in the correspond- 
ing livers, extends earlier esults [121 that suggested 
species differences in tissue localization of carnitine 
synthesis. These finding strongly argue against the 
prevailing eneralization, based on studies carried out 
almost exclusively with the rat, that the liver is the 
exclusive or primary site of carnitine synthesis. 
Table 1 
y-Butyrobetaine hydroxylase activity in human and monkey tissue extracts 
Animal 
species 
Specific activity (nkat/g protein) 
Kidney Liver Muscle 
Human 1. D.H., autopsied 12 h 13.6 14.8a 
16.3b 
1.09 1.05a - 
after death 1.02b - 
13.7bpc 0.74bJ - 
2. M.M., autopsied 4.5 h 8.50 0.94 0.00 
after death 10.2b 1.35b o.oob 
11.8byd 2.01bpd o.oob*d 
3. L.L., autopsied 2.5 h 22.3 0.62 - 
after death 21.6e - - 
4. M.C., autopsied 6 h 12.8 0.33 
after death 
Cebus monkey 1. 1 .oo 3.11 - 
(Cebus ape&) 2. 0.77 4.72 - 
Rhesus monkey 1. 26.6 13.5, 16.gf - 
(Macaca mulatto) 2. 9.60 3.40 - 
3. 24.4 19.7 - 
4. 17.4 6.65 - 
5. 14.2 9.21 - 
6. 15.8 9.62 _ 
7. 23.3 10.4 - 
a Assayed in presence of 0.3% Triton X-100, a concentration of detergent in the assay mixture equiv- 
alent to that present when tissue samples extracted in the presence of Triton X-100 were used 
b Tissue samples extracted with buffer containing 1% Triton X-100 
c Extracts freshly prepared from frozen-stored tissues 6 days later 
d Extracts freshly prepared from frozenstored tissues 5 days later 
e Extracts freshly prepared from frozen-stored tissues 2 days later 
f Extracts prepared from tissue sampled from another liver lobe 
Case 1: D. H., autopsy report no. A78-54,65 year old female. Cause of death: bronchopneumonia in a 
patient with disseminated breast carcinoma. Tissue pathological abnormalities: kidney, mild arterio- 
larnephrosclerosis; liver, fatty infiltration and microscopic foci of metastatic arcinoma subcapsularly 
Case 2: M. M., autopsy report no. A78-77,62 year old male. Cause of death: dissecting aneurysm of 
ascending aorta. Tissue pathological abnormalities: kidney, mild arteriolarnephorsclerosis; liver, none; 
striated muscle, none 
Case 3: L. L., autopsy report no. A78-94,82 year old male. Cause of death: perforation of carcinoma 
of stomach with acute peritonitis, massive liver metastases. Tissue pathological abnormalities: kidney, 
mild arteriolarnephrosclerosis; liver, extensive metastatic arcinoma 
Case 4: M. C., autopsy report no. A78-115,43 year old female. Cause of death: metastatic carcinoma 
distal and local (with genito-urinary obstructive disease) from primary origin in Bartholin’s gland. 
Tissue pathological abnormalities: kidney, extensive acute pyelonephritis, papillary necrosis; liver, 
metastatic carcinoma mild focal fatty change. Because of the diffuse microscopic nature of the acute 
pyelonephritis in this individual, it is possible that the kidney sample contained considerable numbers 
of polymorphonuclear leukocytes and bacteria 
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